OCT4 abnormally activated pseudogene 5 (OCT4-pg5) can enhance cell proliferation by competing with miR-145 in endometrial carcinoma via upregulating OCT4 expression [7]. This evidence concerns the gene POU5F1 and endometrial carcinoma.